S1P receptor agonist

This page covers all S1P receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sphingosine-1-phosphate receptor 1 (S1P1).

Targets

Sphingosine-1-phosphate receptor 1 (S1P1)

Phase 3 pipeline (1)

• Centhaquine + Standard Treatment · Pharmazz, Inc. · Critical Care / Shock Management
  Centhaquine is a first-in-class small molecule that activates sphingosine-1-phosphate receptors to improve microcirculation and reduce cellular injury in shock states.

Patent intelligence

• s1p receptor agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates